(2026). Topical pyridostigmine for ocular myasthenia gravis: A translational hypothesis. Medical Hypothesis, Discovery and Innovation in Ophthalmology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Topical Pyridostigmine for Ocular Myasthenia Gravis: A Translational Hypothesis."
Medical Hypothesis, Discovery and Innovation in Ophthalmology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Topical Pyridostigmine for Ocular Myasthenia Gravis: A Translational Hypothesis."
Medical Hypothesis, Discovery and Innovation in Ophthalmology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.